Public Profile

Bharat Biotech Ltd.

Bharat Biotech Ltd., a prominent player in the biotechnology sector, is headquartered in Hyderabad, India. Founded in 1996, the company has established itself as a leader in vaccine development and biopharmaceuticals, focusing on innovative solutions for infectious diseases. With a robust portfolio that includes vaccines for diseases such as typhoid, hepatitis, and COVID-19, Bharat Biotech is renowned for its commitment to research and development. The company’s unique approach combines cutting-edge technology with a strong emphasis on safety and efficacy, setting it apart in the competitive landscape. Recognised for its significant contributions to public health, Bharat Biotech has achieved notable milestones, including the development of India’s first indigenous COVID-19 vaccine. Its strategic operations extend across various regions, reinforcing its position as a key player in the global biotechnology industry.

DitchCarbon Score

How does Bharat Biotech Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

9

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Bharat Biotech Ltd.'s score of 9 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

38%

Bharat Biotech Ltd.'s reported carbon emissions

Bharat Biotech Ltd., headquartered in India, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined in their initiatives. Without concrete figures or defined goals, it is challenging to assess their carbon footprint or climate strategy. However, as a player in the biotechnology sector, Bharat Biotech is likely aware of the growing importance of sustainability and may be engaging in industry-standard practices to address climate change. The company’s future commitments and actions will be crucial in aligning with global climate goals and reducing environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Bharat Biotech Ltd.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Bharat Biotech Ltd. is headquartered in IN, which has a rank of very high, indicating very high grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Bharat Biotech Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Glaxosmithkline

GB
Medical, precision and optical instruments, watches and clocks (33)
Updated about 22 hours ago

Cansino Biologics

CN
Research and development services (73)
Updated 5 days ago

VBI Vaccines Inc.

US
Health and social work services (85)
Updated 5 days ago

CHINA NATIONAL PHARMACEUTICAL GROUP

CN
Chemicals nec
Updated 5 days ago

Sinovac Biotech Ltd.

CN
Health and social work services (85)
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers